FDA issued a Warning Letter to Kyowa Hakko Bio Co., Ltd. on 8/10/2018 as a result of this inspection.
483 Kyowa Hakko Bio Sep 2017

483 Kyowa Hakko Bio Sep 2017

Milva Melendez FDA$119.00 - Available Now

FDA investigators audited the Kyowa Hakko Bio - Hofu, Japan facility and issued inspectional observations (via FDA 483) on 08 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Sep 2017
  • Location: Hofu, Japan
  • FEI: 3002807424
Add To Cart